Moderna had been awarded over $750 million to develop a vaccine against bird flu, which has been circulating in farm animals and sickening people.

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Moderna has interim data it says support advancing its avian influenza vaccine into a late-stage clinical trial, but the U.S. government has canceled the federal contract that would have financed ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

How a bird flu pandemic could emerge 06:21. The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses ...

A veterinarian vaccinates an Egyptian vulture against avian influenza at the Mulhouse zoo, eastern France, in 2020. Moderna had been developing a vaccine to combat an outbreak of bird flu in dairy ...

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

Moderna says its H5 bird flu vaccine showed promising results in a trial. ... Avian influenza, or bird flu, is a broad term that refers to several types of influenza that normally infect birds.

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Moderna in January was awarded $590 million by the Biden administration to advance the development of its bird flu vaccine, and support the expansion of clinical studies for up to five additional ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.